School of Psychology, University of Wollongong, Wollongong, Australia.
Illawarra Health and Medical Research Institute, Wollongong, Australia.
Drug Alcohol Rev. 2021 May;40(4):540-552. doi: 10.1111/dar.13191. Epub 2020 Nov 5.
The collection of routine outcome measurement (ROM) data provides an opportunity for service providers to conduct benchmarking to inform quality assurance practices. To conduct comparative benchmarking, it is important that services have access to comparative data. This paper aims to establish effectiveness indicators for ROM data collected within the alcohol and other drug (AOD) sector.
ROM data were collected by specialist non-government AOD treatment services within the Network of Alcohol and other Drugs Agencies online database (i.e. NADAbase). All participants were attending treatment within New South Wales, Australia (N = 21 572). Effectiveness indicators were calculated by using effect sizes, standard error of measurement, and rates of reliable and clinically significant change. The study focused on quality of life (EUROHIS Quality of Life Scale), psychological distress (Kessler-10) and substance dependence (Substance Dependence Scale).
Since 2010, 21 572 unique people have completed at least one NADAbase Client Outcome Measure. Amphetamines (36%) and alcohol (32%) were the most commonly reported primary substances of concern. Effectiveness indicators were established for the total sample, as well as for people attending residential rehabilitation (n = 8161) and community-based (n = 10 306) treatment services. Standard error of measurement was the least stringent effectiveness indicator (i.e. a higher proportion of people demonstrated improvement), while the clinically significant change was the most stringent approach.
The study demonstrated the utility of the NADAbase to establish effectiveness indicators for benchmarking purposes. Recommendations are provided for the use of benchmarking to inform quality assurance activities in the sector.
常规结果测量(ROM)数据的收集为服务提供者提供了进行基准测试以告知质量保证实践的机会。为了进行比较基准测试,服务部门必须能够获得比较数据。本文旨在为酒精和其他药物(AOD)领域内收集的 ROM 数据建立有效性指标。
ROM 数据由专门的非政府 AOD 治疗服务机构在网络酒精和其他药物机构在线数据库(即 NADAbase)中收集。所有参与者均在澳大利亚新南威尔士州(N = 21572)接受治疗。使用效果大小、测量标准误差和可靠且临床显著变化的比率来计算有效性指标。该研究侧重于生活质量(EUROHIS 生活质量量表)、心理困扰(Kessler-10)和物质依赖(物质依赖量表)。
自 2010 年以来,已有 21572 个独特的人完成了至少一次 NADAbase 客户结果测量。安非他命(36%)和酒精(32%)是最常报告的主要关注物质。为总样本以及参加住院康复(n = 8161)和社区(n = 10306)治疗服务的人建立了有效性指标。测量标准误差是最不严格的有效性指标(即更多的人表现出改善),而临床显著变化是最严格的方法。
该研究证明了 NADAbase 用于建立基准测试目的的有效性指标的实用性。为使用基准测试为该领域的质量保证活动提供了建议。